{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:15:25Z","timestamp":1777396525201,"version":"3.51.4"},"reference-count":59,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,8,18]]},"DOI":"10.3233\/jad-200381","type":"journal-article","created":{"date-parts":[[2020,6,23]],"date-time":"2020-06-23T11:02:24Z","timestamp":1592910144000},"page":"1317-1337","source":"Crossref","is-referenced-by-count":14,"title":["New BACE1 Chimeric Peptide Inhibitors\u00a0Selectively Prevent A\u03b2PP-\u03b2 Cleavage Decreasing Amyloid-\u03b2 Production and Accumulation in Alzheimer\u2019s Disease Models"],"prefix":"10.1177","volume":"76","author":[{"given":"Rosa","family":"Resende","sequence":"first","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Institute for Interdisciplinary Research (IIIUC), Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marisa","family":"Ferreira-Marques","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Pharmacology, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patr\u00edcia","family":"Moreira","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Pharmacology, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judite R.M.","family":"Coimbra","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salete J.","family":"Baptista","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"Chem4Pharma, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Isidoro","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology, Department of Health Sciences, Universit\u00e0 del Piemonte Orientale \u201cA. Avogadro\u201d, Novara, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge A.R.","family":"Salvador","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Pharmaceutical Chemistry, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa C.P.","family":"Dinis","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Biochemistry and Biology, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cl\u00e1udia F.","family":"Pereira","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Medicine, Institute of Biochemistry, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armanda E.","family":"Santos","sequence":"additional","affiliation":[{"name":"University of Coimbra, Center for Innovative Biomedicine and Biotechnology (CIBB), Center for Neuroscience and Cell Biology (CNC), Coimbra, Portugal"},{"name":"University of Coimbra, Faculty of Pharmacy, Laboratory of Biochemistry and Biology, Coimbra, Portugal"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-200381_ref1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-200381_ref2","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.1038\/nrdp.2015.56","article-title":"Alzheimer\u2019s disease","volume":"1","author":"Masters","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.3233\/JAD-200381_ref3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jshs.2016.10.004","article-title":"BACE1 inhibition as a therapeutic strategy for Alzheimer\u2019s disease","volume":"5","author":"Vassar","year":"2016","journal-title":"J Sport Health Sci"},{"key":"10.3233\/JAD-200381_ref4","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.biopsych.2017.08.001","article-title":"Modulation of gamma- and beta-secretases as early prevention against Alzheimer\u2019s disease","volume":"83","author":"Voytyuk","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-200381_ref5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer\u2019s disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.3233\/JAD-200381_ref6","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ng0892-345","article-title":"A pathogenic mutation for probable Alzheimer\u2019s disease in the APP gene at the N-terminus of beta-amyloid","volume":"1","author":"Mullan","year":"1992","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-200381_ref7","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","article-title":"A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline","volume":"488","author":"Jonsson","year":"2012","journal-title":"Nature"},{"key":"10.3233\/JAD-200381_ref8","doi-asserted-by":"crossref","first-page":"30990","DOI":"10.1074\/jbc.M114.589069","article-title":"Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein","volume":"289","author":"Maloney","year":"2014","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-200381_ref9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nn.4188","article-title":"Visualizing APP and BACE-1 approximation in neurons yields insight into the amyloidogenic pathway","volume":"19","author":"Das","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-200381_ref10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.tins.2016.01.003","article-title":"BACE1 Physiological functions may limit its use as therapeutic target for Alzheimer\u2019s disease","volume":"39","author":"Barao","year":"2016","journal-title":"Trends Neurosci"},{"key":"10.3233\/JAD-200381_ref11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s12031-016-0800-1","article-title":"Functions of the Alzheimer\u2019s disease protease BACE1 at the synapse in the central nervous system","volume":"60","author":"Munro","year":"2016","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-200381_ref12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40035-017-0093-5","article-title":"Role of BACE1 in Alzheimer\u2019s synaptic function","volume":"6","author":"Das","year":"2017","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JAD-200381_ref13","doi-asserted-by":"crossref","first-page":"eaao5620","DOI":"10.1126\/scitranslmed.aao5620","article-title":"Axonal organization defects in the hippocampus of adult conditional BACE1 knockout mice","volume":"10","author":"Ou-Yang","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-200381_ref14","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1084\/jem.20171831","article-title":"BACE1 deletion in the adult mouse reverses preformed amyloid deposition and improves cognitive functions","volume":"215","author":"Hu","year":"2018","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-200381_ref15","doi-asserted-by":"crossref","first-page":"26326","DOI":"10.1074\/jbc.M611687200","article-title":"Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice","volume":"282","author":"McConlogue","year":"2007","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-200381_ref16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/ana.24969","article-title":"Decreased plasma beta-amyloid in the Alzheimer\u2019s disease APP A673T variant carriers","volume":"82","author":"Martiskainen","year":"2017","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-200381_ref17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13195-014-0089-7","article-title":"BACE1 inhibitor drugs in clinical trials for Alzheimer\u2019s disease","volume":"6","author":"Vassar","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-200381_ref18","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3389\/fchem.2018.00178","article-title":"Highlights in BACE1 inhibitors for Alzheimer\u2019s disease treatment","volume":"6","author":"Coimbra","year":"2018","journal-title":"Front Chem"},{"key":"10.3233\/JAD-200381_ref19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40035-016-0061-5","article-title":"Stepping closer to treating Alzheimer\u2019s disease patients with BACE1 inhibitor drugs","volume":"5","author":"Yan","year":"2016","journal-title":"Transl Neurodegener"},{"key":"10.3233\/JAD-200381_ref20","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1080\/13543784.2017.1369527","article-title":"Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer\u2019s disease","volume":"26","author":"Moussa","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-200381_ref21","doi-asserted-by":"crossref","first-page":"0139652","DOI":"10.1371\/journal.pone.0139652","article-title":"Cell-penetrating peptides selectively cross the blood-brain barriere in vivo","volume":"10","author":"Stalmans","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-200381_ref22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1126\/science.1072873","article-title":"Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions","volume":"298","author":"Aarts","year":"2002","journal-title":"Science"},{"key":"10.3233\/JAD-200381_ref23","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm911","article-title":"A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia","volume":"9","author":"Borsello","year":"2003","journal-title":"Nat Med"},{"key":"10.3233\/JAD-200381_ref24","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.cell.2009.12.055","article-title":"DAPK1 interaction with NMDA receptor NR2B subunits mediates brain damage in stroke","volume":"140","author":"Tu","year":"2010","journal-title":"Cell"},{"key":"10.3233\/JAD-200381_ref25","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1600-0854.2007.00572.x","article-title":"A comprehensive model for the cellular uptake of cationic cell-penetrating peptides","volume":"8","author":"Duchardt","year":"2007","journal-title":"Traffic"},{"key":"10.3233\/JAD-200381_ref26","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","article-title":"Cell-penetrating peptides: From basic research to clinics","volume":"38","author":"Guidotti","year":"2017","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-200381_ref27","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.celrep.2016.01.076","article-title":"Specific Inhibition of beta-Secretase Processing of the Alzheimer disease amyloid precursor protein","volume":"14","author":"Ben Halima","year":"2016","journal-title":"Cell Rep"},{"key":"10.3233\/JAD-200381_ref28","unstructured":"Chemical Computing Group ULC (2016) Molecular Operating Environment (MOE), 2016.08; Chemical Computing Group ULC, Canada."},{"key":"10.3233\/JAD-200381_ref29","doi-asserted-by":"crossref","first-page":"11225","DOI":"10.1021\/ja9621760","article-title":"Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids","volume":"118","author":"Jorgensen","year":"1996","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JAD-200381_ref30","doi-asserted-by":"crossref","first-page":"W449","DOI":"10.1093\/nar\/gkw329","article-title":"PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex","volume":"44","author":"Lamiable","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.3233\/JAD-200381_ref31","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1021\/ja026939x","article-title":"HADDOCK: A protein-protein docking approach based on biochemical or biophysical information","volume":"125","author":"Dominguez","year":"2003","journal-title":"J Am Chem Soc"},{"key":"10.3233\/JAD-200381_ref32","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2012.06.025","article-title":"Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments","volume":"1471","author":"Cagnin","year":"2012","journal-title":"Brain Res"},{"key":"10.3233\/JAD-200381_ref33","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.nbd.2010.08.008","article-title":"Excitotoxicity through Ca2+-permeable AMPA receptors requires Ca2+-dependent JNK activation","volume":"40","author":"Vieira","year":"2010","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-200381_ref34","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.3233\/JAD-200381_ref35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1177\/0023677215618618","article-title":"Euthanasia using gaseous agents in laboratory rodents","volume":"50","author":"Valentim","year":"2016","journal-title":"Lab Anim"},{"key":"10.3233\/JAD-200381_ref36","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1093\/jnci\/djp100","article-title":"Effect of RasGAP N2 fragment-derived peptide on tumor growth in mice","volume":"101","author":"Michod","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"10.3233\/JAD-200381_ref37","doi-asserted-by":"crossref","first-page":"E36","DOI":"10.1371\/journal.pbio.0020036","article-title":"Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide","volume":"2","author":"Snyder","year":"2004","journal-title":"PLoS Biol"},{"key":"10.3233\/JAD-200381_ref38","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer\u2019s disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem Soc Rev"},{"key":"10.3233\/JAD-200381_ref39","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/mt.2009.281","article-title":"The use of inhibitors to study endocytic pathways of gene carriers: Optimization and pitfalls","volume":"18","author":"Vercauteren","year":"2010","journal-title":"Mol Ther"},{"key":"10.3233\/JAD-200381_ref40","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.tips.2010.07.006","article-title":"In vivo biodistribution and efficacy of peptide mediated delivery","volume":"31","author":"Jarver","year":"2010","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-200381_ref41","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1474-4422(13)70276-X","article-title":"Targeting the beta secretase BACE1 for Alzheimer\u2019s disease therapy","volume":"13","author":"Yan","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-200381_ref42","doi-asserted-by":"crossref","first-page":"14537","DOI":"10.1523\/JNEUROSCI.2692-08.2008","article-title":"Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus","volume":"28","author":"Puzzo","year":"2008","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200381_ref43","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","article-title":"Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: Differential effects of APOE genotype and presenilin mutations","volume":"157","author":"Cataldo","year":"2000","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-200381_ref44","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.biopsych.2016.12.023","article-title":"Beta-site amyloid precursor protein cleaving enzyme 1 inhibition impairs synaptic plasticity via seizure protein 6","volume":"83","author":"Zhu","year":"2018","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-200381_ref45","first-page":"76","article-title":"Chapter 4. Antigens and antibodies","volume":"Sixth ed.","author":"Kindt","year":"2007","journal-title":"Kuby Immunology"},{"key":"10.3233\/JAD-200381_ref46","doi-asserted-by":"crossref","first-page":"6931","DOI":"10.1523\/JNEUROSCI.2262-14.2015","article-title":"Centrally delivered BACE1 inhibitor activates microglia, and reverses amyloid pathology and cognitive deficit in aged Tg2576 Mice","volume":"35","author":"Thakker","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200381_ref47","doi-asserted-by":"crossref","first-page":"8631","DOI":"10.1073\/pnas.1708106114","article-title":"BACE inhibition-dependent repair of Alzheimer\u2019s pathophysiology","volume":"114","author":"Keskin","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-200381_ref48","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1096\/fj.10-167213","article-title":"Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice","volume":"25","author":"Chang","year":"2011","journal-title":"FASEB J"},{"key":"10.3233\/JAD-200381_ref49","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1523\/JNEUROSCI.2884-10.2010","article-title":"A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer\u2019s disease","volume":"30","author":"Fukumoto","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200381_ref50","doi-asserted-by":"crossref","first-page":"363ra150","DOI":"10.1126\/scitranslmed.aad9704","article-title":"The BACE1 inhibitor verubecestat (MK-8931) reduces CNS beta-amyloid in animal models and in Alzheimer\u2019s disease patients","volume":"8","author":"Kennedy","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-200381_ref51","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1523\/JNEUROSCI.4129-14.2015","article-title":"The potent BACE1 inhibitor LY2886721 elicits robust central Abeta pharmacodynamic responses in mice, dogs, and humans","volume":"35","author":"May","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-200381_ref52","doi-asserted-by":"crossref","first-page":"e9316","DOI":"10.15252\/emmm.201809316","article-title":"The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer\u2019s disease","volume":"10","author":"Neumann","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-200381_ref53","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1706441","article-title":"Randomized trial of verubecestat for mild-to-moderate Alzheimer\u2019s disease","volume":"378","author":"Egan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-200381_ref54","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer\u2019s disease: A longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-200381_ref55","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00401-017-1804-9","article-title":"BACE1 inhibition more effectively suppresses initiation than progression of beta-amyloid pathology","volume":"135","author":"Peters","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-200381_ref56","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1567205012666141218125042","article-title":"Beneficial effects of the beta-secretase inhibitor GRL-8234 in 5XFAD Alzheimer\u2019s transgenic mice lessen during disease progression","volume":"12","author":"Devi","year":"2015","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-200381_ref57","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1084\/jem.20171484","article-title":"Combination anti-Abeta treatment maximizes cognitive recovery and rebalances mTOR signaling in APP mice","volume":"215","author":"Chiang","year":"2018","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-200381_ref58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer\u2019s disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.3233\/JAD-200381_ref59","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1021\/bc200293d","article-title":"Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo","volume":"22","author":"Suhorutsenko","year":"2011","journal-title":"Bioconjug Chem"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-200381","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:31Z","timestamp":1777370911000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-200381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":59,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-200381","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]}}}